Currency headwinds push Hikma Pharmaceuticals profits down
(ShareCast News) - Drug group Hikma Pharmaceuticals reported revenue of $1.44bn (£1.02bn) in its final results for 2015 on Wednesday, down 3% on what was an exceptionally strong 2014. Its gross margin remained in line with 2014, at 56.8%, reflecting Hikma's cost control efforts across the business.
Read more